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Background: The ability to identify regions of the genome inherited with a dominant trait in one or more families
has become increasingly valuable with the wide availability of high throughput sequencing technology. While a
number of methods exist for mapping of homozygous variants segregating with recessive traits in consanguineous
families, dominant conditions are conventionally analysed by linkage analysis, which requires computationally
demanding haplotype reconstruction from marker genotypes and, even using advanced parallel approximation
implementations, can take substantial time, particularly for large pedigrees. In addition, linkage analysis lacks
sensitivity in the presence of phenocopies (individuals sharing the trait but not the genetic variant responsible).
Combinatorial Conflicting Homozygosity (CCH) analysis uses high density biallelic single nucleotide polymorphism
(SNP) marker genotypes to identify genetic loci within which consecutive markers are not homozygous for different
alleles. This allows inference of identical by descent (IBD) inheritance of a haplotype among a set or subsets of
related or unrelated individuals.
Results: A single genome-wide conflicting homozygosity analysis takes <3 seconds and parallelisation permits
multiple combinations of subsets of individuals to be analysed quickly. Analysis of unrelated individuals demonstrated
that in the absence of IBD inheritance, runs of no CH exceeding 4 cM are not observed. At this threshold, CCH is >97%
sensitive and specific for IBD regions within a pedigree exceeding this length and was able to identify the locus
responsible for a dominantly inherited kidney disease in a Turkish Cypriot family in which six out 17 affected individuals
were phenocopies. It also revealed shared ancestry at the disease-linked locus among affected individuals from two
different Cypriot populations.
Conclusions: CCH does not require computationally demanding haplotype reconstruction and can detect
regions of shared inheritance of a haplotype among subsets of related or unrelated individuals directly from
SNP genotype data. In contrast to parametric linkage allowing for phenocopies, CCH directly provides the exact
number and identity of individuals sharing each locus. CCH can also identify regions of shared ancestry among
ostensibly unrelated individuals who share a trait. CCH is implemented in Python and is freely available (as source
code) from http://sourceforge.net/projects/cchsnp/.
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Genetic analysis of multiply affected pedigrees has seen
a resurgence of interest in the post-GWAS era [1,2].
Typically, in order to identify parts of the genome that
segregate with a trait in a pedigree, linkage analysis is
performed using haplotypes reconstructed from a large
number of biallelic single nucleotide polymorphism
(SNP) genotypes. Although the underlying SNP geno-
typing is robust and inexpensive, the analysis can be
computationally demanding and time consuming.
While effective and rapid methods exist for mapping
homozygous alleles responsible for recessive traits in
consanguineous families, identification of shared
heterozygous variants causing dominant traits can be
more computationally demanding. Owing to the
exponential increase in computational requirements with
increasing pedigree size for exact algorithms (e.g. Lander-
Green), large families (especially those with many non-
founders) pose a particular analytical challenge. Two
commonly utilised approaches include pedigree splitting
[3], which can result in significant loss of power [4], or
the use of Markov chain Monte Carlo (MCMC) approxi-
mation [5]. The latter can still be computationally
intensive, time consuming, and can fail to converge. Some
of these problems have been overcome by a recent
parallel implementation of the MCMC method [6].
A second problem in the analysis of extended pedigrees
is that if some individuals are phenocopies (individuals
that share the phenotype under consideration but not the
genetic variant responsible for the trait in other family
members) this causes erroneous exclusion of the causative
locus, since phenocopies lack the true disease-linked
haplotype. Although parametric linkage analyses can be
performed under the hypothesis of a specified phenocopy
rate, a priori this rate is unknown and analyses are
sensitive to model misspecification [7] so analyses may
have to be repeated across a range of parameters and
significance thresholds adjusted accordingly [8]. Even
utilising an appropriate phenocopy rate or conductingFigure 1 Conflicting homozygosity (CH) occurs when two or more ind
and indicates that these individuals cannot all share a haplotype span
descent inheritance at that locus.non-parametric linkage can result in failure to identify the
responsible locus or prioritisation of the incorrect locus
[9]. Furthermore, including phenocopies in whole genome
or whole exome sequencing strategies will similarly
prevent detection (or lead to erroneous exclusion) of the
causative variant. These considerations have limited
genetic studies in single families to those in which the
phenotype is so rare or distinctive that phenocopies are
extremely unlikely.
We have developed a tool called Combinatorial
Conflicting Homozygosity (CCH) that addresses these
challenges. Rather than calculating the likely flow of
haplotypes through a family, CCH uses dense SNP geno-
types to identify individual markers that cannot have been
inherited identical-by-descent (IBD) among a set of
individuals from a recent common ancestor. This
allows identification of regions of the genome that con-
tain consecutive markers in which IBD inheritance is not
excluded. We show that above a threshold size (of 4 cM in
the example here) the probability that such regions are not
the result of IBD inheritance becomes vanishingly small.
This exclusion approach contrasts with homozygosity map-
ping (which is used to map recessive, not dominant alleles)
in which identical homozygous genotypes define the subset
of the genome included in analysis. We demonstrate how
CCH can be used to identify regions of the genome where
a single haplotype is shared by some, but not all, members
of a family and that this information can be used to identify
individuals harboring a heterozygous disease-linked
variant in a family with multiple phenocopies, and com-
pare CCH with traditional parametric linkage analysis.
Unlike pedigree-based linkage methods used to analyse
dominant traits, this approach is equally applicable to
related and unrelated individuals or combinations thereof.
Methods
CCH algorithm and implementation
The underlying algorithm of CCH is based on the simple,
previously described principle that inheritance of at leastividuals are homozygous for different SNP alleles (e.g. AA and BB)
ning this SNP. The absence of CH is consistent with identical by
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excluded by the occurrence of SNPs homozygous for differ-
ent alleles, i.e. identical-by-state for zero alleles (IBS0)
[10,11] (a situation we term conflicting homozygosity, CH,
Figure 1). CCH uses this principle to infer IBD inheritance
at loci where, in a group of individuals, CH is not observed
across numerous consecutive SNPs. To do this, the number
of consecutive SNPs for which CH is not observed among
the individuals under consideration is summated at each
locus along a chromosome. This process is then repeated
for each chromosome. Short runs of consecutive SNPs
demonstrating no CH occur by chance in unrelated indi-
viduals but runs of no CH exceeding a threshold length are
indicative of IBD inheritance. To militate against the effect
of genotyping errors, single occurrences of CH that directly
separate two loci whose combined length exceeds the
pre-determined threshold are ignored. CCH analysis con-
trasts with homozygosity mapping analyses (such as those
implemented in PLINK [12] and HomozygosityMapper
[13]) which are used to identify loci underlying recessive
traits, both in its underlying principle (described above)
and because CCH is designed to locate dominant (as
opposed to recessive) alleles.
The rapidity of a single genome-wide CH analysis per-
mits repeated analyses to be undertaken testing for IBD
inheritance among all nCk combinations of subsets of k
from n individuals. The complete independence of each
analysis permits extensive parallelisation depending on
the available computational resources. CCH is imple-
mented in Python and the source code, along with an
example dataset and user instructions are available from
http://sourceforge.net/projects/cchsnp/. This program
enables analyses to be undertaken, results plotted and
includes a feature to permit the generation and processing
of segmented files for parallelisation. Scripts to prepare
input files from PLINK [12] and high throughput
sequencing (.vcf) formats [14] are also provided.
CH among subsets of unrelated individuals
To determine the distribution of CH among unrelated
individuals we used SNP genotypes corresponding to the
Illumina HumanCytoSNP 12v2 array (Illumina, CA) of
approximately 300,000 SNPs taken from the HapMap
Project [15]. Groups of between 8 and 15 unrelated
HapMap individuals (identifiers of all individuals utilised
are listed in Additional file 1: Table S1) were selected
and CCH was used to sequentially analyse all possible
subsets of all of these groups. The analysis was repeated
100 times for each group size using different, randomly
selected, HapMap individuals. The mean density of this
SNP array is approximately 100 SNPs per cM and we
exclude all runs of <100 SNPs in length to prevent
detecting a false positive signal from regions of the
genome with sparse SNP coverage.Genotyping and linkage analysis in an example family
All research involving human participants was performed
with written informed consent and was approved by the
ethics committee of Lefkosa Burhan Nalbantoğlu State
Hospital. All participants provided informed consent for
their involvement in the research in accordance with
the Declaration of Helsinki and for the publication of
the study results. Individuals were genotyped on the
HumanCytoSNP 12v2 array (Illumina, CA) according
to the manufacturers’ instructions. Genotype data have
been deposited in the NCBI Gene Expression Omnibus
(GEO) [16] and are accessible through GEO Series
accession number GSE65312. Standard quality control
[17] was undertaken using PLINK [12] to remove SNPs
with >5% missingness, <5% minor allele frequency or
deviation from Hardy-Weinberg equilibrium (p < 1 × 10-6).
SNPs demonstrating Mendelian errors were removed. A
cohort of 17 unrelated population-matched controls
genotyped on the same array were used to prune for LD
at r2 < 0.2. From these, the SNP with the highest heterozy-
gosity within the family and lowest frequency in the
controls within 0.5 cM windows were selected. This
yielded 5,344 informative SNPs for linkage. Affected-
only parametric linkage analyses was undertaken with
SwiftLink [6] using default parameters with a disease
allele frequency of 0.0001 and variable phenocopy
rates. Input files for SwiftLink were generated using
MEGA2 [18]. As SwiftLink utilises an MCMC estimation-
based approach it is necessary to repeat each analysis a
number of times and take the average LOD score. Each
chromosome was thus analysed ten times in parallel.Results and discussion
Marker diversity, linkage disequilibrium, the null
distribution and CH threshold
SNPs with low minor allele frequency (MAF) are likely to
be identical by state purely by chance, so we sought to
determine whether CCH might indicate apparent regions
of IBD inheritance because of low marker diversity.
However, since it only takes a single instance of CH to
break up a haplotype, we hypothesised that CCH analysis
would be relatively robust to this effect: very large numbers
of consecutive markers showing no CH would be required
to mimic the very large (cM-scale) haplotypes inherited
within a family. Similarly, local linkage disequilibrium (LD)
between nearby markers mean that blocks of alleles tend to
be inherited together even in the absence of IBD inherit-
ance from a recent common ancestor. In the Caucasian
population, fewer than 10% of SNPs separated by 160 kbp
(typically <0.2 cM) show significant evidence of LD, and
where the recombination rate (i.e. the number of cM per
megabase-pair) is greater, the span of LD tends to be
reduced [19]. We therefore hypothesised that such
Figure 3 Length of no CH among all possible subsets of groups
of size (n) = 8 to 15 randomly selected individuals from the
HapMap database. 100 replicates of each group size were
performed and the maximum run lengths in cM across all replicates
of all combinations of possible subsets of every group are plotted
(i.e. 6.5 × 106 genome-wide CH analyses). For subsets including 4 or
more (unrelated) individuals, no runs extending 4 cM or more
were observed.
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the very large haplotypes inherited within a family.
To test these hypotheses we examined the distribu-
tions of no CH run lengths in all possible subsets of
between 8 and 15 unrelated HapMap individuals,
repeated 100 times using different HapMap individuals.
The run lengths (in cM) of no CH observed in these
analyses were distributed exponentially (Figure 2) about
a mean which varies as a function of the number of
individuals being compared. The maximum observed
run lengths in cM across all 100 analyses for each group
size are plotted in Figure 3. Across all 6.5 × 106 of these
genome-wide CH analyses, when subsets comprising 4 or
more unrelated individuals (whatever the group size) were
included, no runs comprising >100 SNPs and extending
>4 cM in length were observed. Since CH cannot occur
among a set of individuals at a locus where a haplotype is
shared (since at least one allele of each SNP in the shared
haplotype must be shared) much longer runs of no CH are
expected to occur in regions of the genome where there is
IBD inheritance of at least one haplotype from a recent
common ancestor. The length of runs arising from IBD
inheritance is dependent on the size of the shared haplo-
type, which decreases as a function of the number of
meioses separating the individuals, starting at an expected
length of ~34 cM (comprising >3,000 SNPs in the array
used in this investigation) for a pair of siblings. When
related individuals (Figure 4A) were analysed using CCH,
an excess of longer run lengths was observed compared
with analysis of the same number of unrelated individuals
(Figure 5). These data show that, at least with this 300,000Figure 2 Histogram showing the distribution of lengths (in cM)
of runs of no CH among 11 unrelated people (genotype data
taken from HapMap database). Run lengths were distributed
exponentially (inset). A similar distribution was seen for all other
groups tested. Dashed lines represent 95% confidence interval.SNP marker set, regions of low haplotype diversity or
strong LD are not large enough to generate a false-
positive signal in the absence of recent shared ancestry,
and therefore imply that longer runs of no CH are likely
to result from IBD inheritance of a haplotype from a
recent common ancestor.
Assessment of statistical significance
The statistical test we use to infer IBD inheritance at a
given locus is the likelihood that the observed length of
no CH at that locus occurred under the null hypothesis
(that is by chance in the absence of recent shared ances-
try among the individuals compared).
Using the observed underlying exponential distribution
of no CH run lengths (Figure 5) to compute these likeli-
hoods we calculate that for 11 unrelated individuals, the
likelihood of observing a run of length >4 cM was <10-7
and >7 cM was <10-12. For combinatorial CH analyses,
these likelihoods should be corrected for the multiple
independent analyses performed (using the Bonferroni
approach this is equivalent to p < 10-2 and p < 10-7 for
4 and 7 cM runs, respectively when tens of thousands
of combinatorial CH analyses are performed, as in the
example pedigree below). Since, in a group of individuals,
any IBD locus could harbor the allele responsible for a
shared inherited trait, the size of the locus (and hence the
p-value for IBD inheritance) does not indicate the likeli-
hood of the allele of interest being located there. Rather, it
represents the likelihood that the locus is inherited IBD by
Figure 4 CCH in a family with kidney disease. A. Family tree showing affected individuals and connecting relatives only. 29 unaffected 1st
degree relatives are omitted. Arrow indicates the proband. CKD: chronic kidney disease, ESKD: end-stage kidney disease. Genotypes for the
COL4A3 p.Gly871Cys mutation are indicated by mutant or wild type respectively, as per the key. B. Combinatorial CH analysis showing the 4 loci
at which there are runs of no CH ≥4 cM in at least 11 of the 17 clinically affected family members. COL4A3 is on chromosome 2 (arrow). Colors
alternate for clarity. C. Genome-wide CCH results showing the maximum number of individuals who are IBD at each locus.
Figure 5 QQ plot showing lengths of runs of >20 SNPs
observed when all combinations of 11 out of 17 affected family
members are analysed using CCH and plotted against
exponential quantiles. Arrow indicates the locus spanning the
COL4A3 gene (uncorrected p = 2.5 × 10-14 given the underlying
exponential distribution). CCH performed with related individuals
yields an excess of longer runs compared with the analysis of the
same number of unrelated individuals drawn from the HapMap
Project (inset).
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identifying loci which cosegregate perfectly with a trait
and therefore exhibit the maximum observed LOD score
within a pedigree, with the magnitude of the maximum
LOD score depending on the certainty with which
haplotypes can be inferred and the family structure. In
genome-wide analyses, these IBD loci (whether detected
by linkage analysis or CCH) represent the subset of the
genome within which a co-segregating allele may lie.
When analysing k out n individuals, the number of
independent analyses, nCk, is equal to n!/(k!(n-k)!). This
number rises exponentially as n and n-k increase, exceed-
ing 108 when n > ~30 and (n-k) > ~10. This places a limit
on the size of groups amenable to CCH analysis due both
to the computing time required for such a large number
of analyses, and also the reduction in statistical power due
to multiple independent tests being performed. Nonethe-
less, CCH analysis remains practical even among large
groups, where < ~8 phenocopies are hypothesized.Sensitivity and specificity of CCH for detecting IBD
inheritance
To assess the sensitivity and specificity of CCH to accur-
ately determine the maximum number of individuals
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wide gene-dropping simulations using the pedigree
structure shown in Figure 4A were performed using
Merlin [20] and repeated 100 times. CCH was run on
the resulting simulated datasets, with the cM detection
threshold varying between 1 and 8 cM (Figure 5). The
founder source of each allele in non-founders was
determined using founder-specific tags adjacent to each
SNP that were removed prior to CCH analysis. CCH
was run on each genome-wide simulated dataset testing
for loci shared IBD by between 6 and 17 individuals.
The maximum number of individuals IBD at each SNP
was identified and compared with the real maximum
(as determined by the inheritance of the founder-
specific tags). Sensitivity was defined as the proportion
of SNPs in IBD loci exceeding the cM threshold
identified by CCH as being shared by the correct
number of individuals. Specificity was the proportion of
SNPs identified as IBD by CCH that were genuinely
IBD. CCH is highly sensitive, and specificity increased
with the cM threshold and the number of individuals
included as assessed by comparison with IBD segments
from gene-dropping simulations. Using a 4 cM
threshold to detect regions inherited IBD in 7 or more
individuals genotyped with this ~300,000 SNP array,
the median sensitivity was 100% (95% CI: 98.6–100%)
and the specificity was 97.7% (95% CI: 95.4–98.4%,
Figure 6).Figure 6 Sensitivity and specificity of CCH to correctly identify the m
recent common ancestor. Data for ≥6 and ≥7 individuals only are shownDouble recombinations
When searching for a disease-causing variant within a
family, we make the assumption that the variant lies
within a shared haplotype that is larger than the detec-
tion threshold – double recombination events immedi-
ately flanking the variant responsible will therefore
prevent its detection by CCH. However, conventional
linkage analysis is similarly susceptible to this possibility:
linkage is performed either with widely spaced
polymorphic markers (typically 300 per genome, mean
spacing ~10 cM) or else with a SNP chip using a
thinned-out set of perhaps 5–10,000 informative biallelic
markers (mean spacing ~0.5 cM) where multiple
consecutive markers are needed to reconstruct a haplo-
type with enough certainty to yield a high-magnitude
LOD score. This means that double-recombinations
flanking small (i.e. sub-cM) regions will be invisible to
haplotype reconstruction algorithms and are therefore
missed regardless of the approach used. Because recom-
binations occur with a median spacing of ~75 cM per
meiosis, when dealing with a small number (i.e. <20)
meioses in a single family, the probability of recombina-
tions occurring so close together at the disease-causing
locus is small. Furthermore, because CCH is robust to the
existence of phenocopies, a small number of individuals in
whom such a double recombination event has occurred
will not prevent detection of the disease-linked haplotype
in the rest of the family when CCH is employed. Inaximum number of individuals inheriting a haplotype IBD from a
.
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linkage analysis is performed with a non-negligible pheno-
copy rate.
Example: an extended multiplex family with apparently
autosomal dominant kidney disease
We investigated a Turkish Cypriot family with apparent
autosomal dominant kidney disease (defined as one or
more of hematuria, proteinuria or renal impairment)
among 19 family members (Figure 4A). No extra-renal
manifestations or renal cysts were detected and no indi-
vidual had undergone a kidney biopsy. Endemic muta-
tions associated with non-cystic kidney disease in the
Greek Cypriot population [21,22] were excluded in the
proband. The 17 affected individuals from whom DNA
was available were genotyped for ~300,000 SNPs.
A genome-wide parametric linkage analysis using a
subset of 5,344 informative SNPs took ~105 hours of
computing time run in parallel 220 fold (ten repeats of
each of the 22 chromosomes) and failed to identify any
loci significantly co-segregating with kidney disease
(Additional file 1: Figures S1A and S1B). The maximum
LOD score was 0.64 at a phenocopy rate of 0.01 and
reached 2.25 at a phenocopy rate of 0.05.
Genome-wide CH analysis of all 300,000 SNPs using a
standard desktop personal computer took <3 seconds
and identified no runs of no CH extending >1.5 cM,
consistent with no regions shared by all 17 affected family
members. We therefore postulated one or more phenocopies
and used CCH to analyse all possible combinations of sub-
sets, of progressively decreasing size, of the 17 clinically af-
fected individuals with a 4 cM threshold. This indicated two
loci (of 16.8 cM and 4.5 cM) shared by 12 individuals. These
loci contain no genes associated with kidney disease, so fur-
ther analyses were performed on all 12,376 possible subsets
of 11 out of 17 individuals. Together, these analyses took ap-
proximately 7 hours to complete serially on a desktop com-
puter and indicated two further loci (of 11.4 and 7.75 cM)
shared by 11 individuals (Figure 4B). The 11.4 cM locus in-
cluded the COL4A3 gene and molecular testing identified, in
all 11 individuals who shared it, a c.2611G >T substitution
(chr2:227282487 using GRCh38, predicting p. Gly871Cys) in
exon 32 of the COL4A3 gene. This variant was absent in un-
affected members of the family and the six phenocopies, in-
cluding the index case. Analyses of smaller subsets identified
11 loci shared by ≥10 and 22 loci shared by ≥9 individuals
(Figure 4C).
Given that the underlying distribution of no CH run
lengths conforms to an exponential distribution (Figures 2
and 5) the likelihood of observing, in the absence of shared
inheritance, a run length of >5 cM is <10-6 and >7 cM is
<5 × 10-9. Even with correction for the several thousand
combinatorial analyses performed we concluded that such
long run lengths were attributable to shared inheritance of ahaplotype. To confirm this, haplotypes at loci identified as
IBD in >10 individuals were reconstructed using SimWalk2
[23], and co-segregation with the relevant individuals was
observed in all cases.
The COL4A3 p.Gly871Cys mutation is associated with
kidney disease in the Greek Cypriot population charac-
terised by microscopic hematuria, with proteinuria and pro-
gressive renal dysfunction occurring in a proportion of
patients in later life [21,24]. Haematuria was present in all
eight non-anuric individuals with the mutation and only
one of the six phenocopies. We conclude that this mutation
explains the kidney disease in these 11 family members.
Additional CH analysis demonstrated part of this same
haplotype (extending 5.7 cM across the mutation) in an
unrelated Greek Cypriot individual with kidney disease
who harbored the same mutation, confirming recent
shared ancestry in affected individuals from these two
communities.
The prevalence of clinical evidence of kidney disease (i.e.
proteinuria, hematuria or renal impairment) in the Turkish
Cypriot population is not known, however one or more of
these abnormalities is detectable in >16% of Australian
adults [25]. Considering that clinical data were available for
48 family members, and given a probability of evidence of
kidney disease of 16% for each person, under a binomial
model that ignores any heritability, the expected number
of individuals with evidence of kidney disease is 7.7,
which is greater than the six observed phenocopies. Fur-
thermore, the probability of observing >5 affected individ-
uals out of 48 exceeds p = 0.05 when the population
prevalence is >5.6%. This implies firstly that additional
Mendelian disease need not be invoked in this family to ex-
plain the observed number of phenocopies, and secondly
that in other families with unexplained kidney disease a
similar proportion of phenocopies may be expected.
Comparison of CCH with parametric linkage analysis
Interrogation of the COL4A3 locus by linkage at variable
phenocopy rates from 0 to 0.45 yielded a maximum LOD
score of 1.4 at a phenocopy rate of 0.25 (Additional file 1:
Figure S2). Performing a genome-wide analysis at pheno-
copy rates of 0.25 and 0.35 (corresponding to the actual
phenocopy rate at the COL4A3 locus) identified numerous
loci with LOD scores exceeding zero and a smaller number
with LOD scores exceeding one (Additional file 1: Figures
S1C and S1D). These loci approximately corresponded
to those obtained by CCH (Additional file 1: Figure
S1E). A flow chart comparing the methodology of
CCH with parametric linkage is shown in Additional
file 1: Figure S3.
CCH has a number of advantages over tradition linkage
approaches: First, CCH directly provides the exact number
and identity of individuals sharing each locus (and thus re-
sponsible for each linkage signal). Second, CCH only
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examination without a need for data from unaffected con-
necting relatives. CCH may thus be particularly useful in
the context of pedigrees in which affected subjects are
distantly related via individuals for whom precise relation-
ship information and DNA is unavailable. Third, pre-
processing of data for CCH is minimal only requiring
standard quality control procedures with no need to gener-
ate an informative marker subset or to provide population
specific allele frequencies. Formatting of the data and
executing the software is therefore straightforward. Finally,
each genome-wide CH analysis of a subset of individuals is
rapid (~2.5 seconds) and completely independent the
analysis of other subsets, thus permitting significant
parallelisation. In the example family under study, to
perform linkage analysis using SwiftLink running on a
four core processor took an average of ~30 minutes
per chromosome. Parallelised 220 fold, each genome-
wide linkage took 3.5 hours (including cluster queuing
time) with a total running time of ~110 hours. Given
that a priori the true phenocopy rate is unknown, this
would have to be repeated multiple times at different
phenocopy rates. By comparison, analysis using CCH of
all possible subsets comprising nine or more of the 17
individuals in the family (i.e. without pre-specifying the
phenocopy rate) with 200 fold parallelisation per subset
size was finished within 30 minutes (including queuing),
with a total running time of ~41 hours. The limit on
computing time with parallel CCH is simply a product of
the number of available cluster nodes.
Conclusions
CCH can rapidly identify the disease-linked locus in
autosomal dominant disease, even in the presence of
multiple phenocopies. CCH is also able to detect regions
of shared ancestry among ostensibly unrelated individ-
uals using un-phased genotypes. We believe that CCH
should be considered in the investigation of inherited
diseases where phenocopies are suspected, and may be
especially powerful in detecting the location of founder
mutations within isolated populations.
Additional file
Additional file 1: Figure S1. Genome-wide affected-only linkage analysis
for the family under study (Figure 4A) undertaken with Swiftlink using an
informative LD-pruned marker set at phenocopy rates of 0.01 (A), 0.05 (B),
0.25 (C) and 0.35 (D). For comparison, the CCH results (Figure 4C) are
reshown here (E). Figure S2. Results of linkage analysis (as per Additional
file 1: Figure S1) at the COL4A3 locus at phenocopy rates from 0 to 0.45.
Figure S3. Flow chart comparing the methodology of CCH with parametric
linkage. Table S1. Identifiers of 60 HapMap CEU individuals utilised in
simulations.
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